Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.
Prostate-specific antigen (PSA) cannot distinguish between benign prostatic hyperplasia (BPH) and prostate cancer (PCa), resulting in a large number of unnecessary biopsies and missed cancer diagnoses. Nanovesicles called exosomes can be directly detected in patient plasma, and plasma exosomes expressing CD81 and PSA in PCa are significantly higher, achieving 100% specificity and sensitivity in distinguishing PCa patients from healthy individuals. Sensitivity.
Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.